Please login to the form below

Not currently logged in
Email:
Password:

Alexza’s Peter Schineller joins Agendia

Appointed first chief commercial officer

Agendia Peter SchinellerCancer diagnostics firm Agendia has appointed Peter Schineller as its first chief commercial officer.

Schineller's appointment marks a swift departure from his previous role at Alexza Pharmaceuticals, which he only joined in March 2013 as senior VP and chief commercial officer.

He has additional healthcare experience as general manager at Roche subsidiary Ventana Medical Systems and as senior VP for sales, marketing and commercial operations at Genoptix Medical Laboratories, a diagnostic firm that was acquired by Novartis.

David Macdonald, Agendia's CEO, explained the creation of the new commercial role: "As we continue our growth momentum into 2013, we are committed to building out a world class organisation capable of managing and growing a much larger company.

"Mr Schineller's depth of experienced senior leadership of global commercial organisations will help us perpetuate our volume growth, which exceeded 140 percent in 2012."

5th June 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics